Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Mini Samples ELISA Kit for Granzyme B (GZMB)
GZM-B; HLP; CTLA1; CCPI; CGL1; CSP-B; CSPB; CTSGL1; SECT; Granzyme 2; Cytotoxic T-Lymphocyte-Associated Serine Esterase 1; Fragmentin 2; Cytotoxic Serine Protease B
- Product No.MEA600Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range15.6-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 5.7pg/mL.
- Downloadn/a
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 545
For more details, please contact local distributors! US$ 778 US$ 3501 US$ 6613 US$ 54460
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Granzyme B (GZMB).
No significant cross-reactivity or interference between Mini Samples Granzyme B (GZMB) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Granzyme B (GZMB) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Granzyme B (GZMB) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 90-101 | 98 |
EDTA plasma(n=5) | 87-99 | 96 |
heparin plasma(n=5) | 82-91 | 87 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Granzyme B (GZMB) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Granzyme B (GZMB) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Granzyme B (GZMB) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-98% | 85-97% | 79-95% | 89-97% |
EDTA plasma(n=5) | 84-101% | 81-98% | 94-101% | 80-103% |
heparin plasma(n=5) | 80-93% | 79-91% | 87-101% | 94-104% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×60µL | Assay Diluent A | 1×6mL |
Detection Reagent B | 1×60µL | Assay Diluent B | 1×6mL |
TMB Substrate | 1×4.5mL | Stop Solution | 1×3mL |
Wash Buffer (30 × concentrate) | 1×10mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
International Journal of Cancer | Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70 Pubmed:24691976 |
Biol Pharm Bull. | Z-100, an Immunomodulatory Extract of Mycobacterium tuberculosis Strain Aoyama B, Prevents Spontaneous Lymphatic Metastasis of B16-BL6 Melanoma Pubmed:24818259 |
Journal of Dermatological Science | Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopicdermatitis. pubmed:27686401 |
Oncotarget | Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment Pubmed:29983866 |
Theranostics | A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors Pubmed: 31695790 |
Am J Transl Res | Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma 34377237 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
RPA600Mu01 | Recombinant Granzyme B (GZMB) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA600Mu02 | Recombinant Granzyme B (GZMB) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA600Mu02 | Polyclonal Antibody to Granzyme B (GZMB) | WB; IHC; ICC; IP. |
PAA600Mu01 | Polyclonal Antibody to Granzyme B (GZMB) | WB; IHC; ICC; IP. |
SEA600Mu | ELISA Kit for Granzyme B (GZMB) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEA600Mu | Mini Samples ELISA Kit for Granzyme B (GZMB) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA600Mu | Multiplex Assay Kit for Granzyme B (GZMB) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |